2seventy bio, Inc.2seventy bio, Inc.2seventy bio, Inc.

2seventy bio, Inc.

No trades
See on Supercharts
Market capitalization
‪259.63 M‬USD
−4.41USD
‪−217.57 M‬USD
‪100.39 M‬USD
‪47.64 M‬
Beta (1Y)
3.51

About 2seventy bio, Inc.

CEO
William Denise Baird
Headquarters
Cambridge
Employees (FY)
274
Founded
2021
ISIN
US9013841070
FIGI
BBG00YV1J622
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TSVT is 4.64 USD — it has decreased by 8.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 2seventy bio, Inc. stocks are traded under the ticker TSVT.
2seventy bio, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
TSVT stock is 9.98% volatile and has beta coefficient of 3.51. Check out the list of the most volatile stocks — is 2seventy bio, Inc. there?
One year price forecast for 2seventy bio, Inc. has a max estimate of 25.00 USD and a min estimate of 5.00 USD.
TSVT earnings for the last quarter are −1.40 USD per share, whereas the estimation was −1.15 USD resulting in a −21.84% surprise. The estimated earnings for the next quarter are −1.04 USD per share. See more details about 2seventy bio, Inc. earnings.
2seventy bio, Inc. revenue for the last quarter amounts to ‪12.00 M‬ USD despite the estimated figure of ‪31.18 M‬ USD. In the next quarter revenue is expected to reach ‪14.71 M‬ USD.
Yes, you can track 2seventy bio, Inc. financials in yearly and quarterly reports right on TradingView.
TSVT stock has fallen by 10.94% compared to the previous week, the month change is a 15.42% rise, over the last year 2seventy bio, Inc. has showed a 48.04% decrease.
TSVT net income for the last quarter is ‪−56.82 M‬ USD, while the quarter before that showed ‪−71.64 M‬ USD of net income which accounts for 20.68% change. Track more 2seventy bio, Inc. financial stats to get the full picture.
Today 2seventy bio, Inc. has the market capitalization of ‪238.08 M‬, it has increased by 11.54% over the last week.
No, TSVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TSVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2seventy bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
TSVT reached its all-time high on Nov 4, 2021 with the price of 64.00 USD, and its all-time low was 1.54 USD and was reached on Nov 22, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 274.00 employees. See our rating of the largest employees — is 2seventy bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 2seventy bio, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 2seventy bio, Inc. stock shows the sell signal. See more of 2seventy bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on 2seventy bio, Inc. future price: according to them, TSVT price has a max estimate of 25.00 USD and a min estimate of 5.00 USD. Read a more detailed 2seventy bio, Inc. forecast: see what analysts think of 2seventy bio, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2seventy bio, Inc. EBITDA is ‪−206.42 M‬ USD, and current EBITDA margin is −205.62%. See more stats in 2seventy bio, Inc. financial statements.